Eli Lilly (LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

Chief Executive David Ricks said the quarter was marked by robust sales for Zepbound and Mounjaro, in addition to momentum across other key medicines. Eli Lilly logged net income of $5.66 billion, or ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

When Eli Lilly reports its financial results early Thursday, investors will be looking for the company to press its advantage ...

Shares in Eli Lilly have come under pressure after reporting the results ... Some analysts had been hoping for a reduction in the area of 15% with the drug, and Lilly's chief executive David Ricks ...

Novo Nordisk also released its second quarter results this week, boasting profit of more than $4 billion. Per-share earnings ...

Yet, within the past 24 hours, Trump has doubled the tariffs on India to 50%, imposed an additional 15% on Japan, announced a ...

Let’s get to the Philadelphia Eagles links … ‘He’s going to be a problem:’ What Saquon Barkley sees in rookie Jihaad Campbell ...